Compare Nuwellis Inc (NUWE) vs BlackRock TCP Capital Corp (TCPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs BlackRock TCP Capital Corp — how do they compare? Nuwellis Inc trades at $2.84 (market cap $1.09M), while BlackRock TCP Capital Corp trades at $3.24 (market cap $270.17M). The key difference: BlackRock TCP Capital Corp is far larger — about 247.9× Nuwellis Inc's market cap, and BlackRock TCP Capital Corp pays a 26.09% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | TCPC | |
|---|---|---|
Market Cap | $1.09M | $270.17M |
Sector | Technology | Financials |
52-Week High | $527.46 | $7.64 |
52-Week Low | $2.80 | $3.14 |
Enterprise Value | -$722.58K | — |
Dividend Yield | — | 26.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $3.00, up 5.26% today, following a 35:1 reverse stock split effective June 26, 2026. The company shows a low P/E of 0.06 and P/S of 0.01, but fundamentals are weak with a -217.22% net income margin and negative ROE. Recent news highlights patent awards and pediatric market expansion, yet cash flow remains negative. Analyst coverage is limited with a split buy/hold consensus.
Outlook is speculative; growth depends on successful commercialization of Aquadex therapy and cost management. Key risks include persistent losses, high cash burn, and competitive pressures. Investors should weigh low valuation against execution risks in the medical technology sector.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About BlackRock TCP Capital Corp
BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →
